Aljosja Karpenko

Aljosja Karpenko possesses extensive experience in market access and strategy within the pharmaceutical field, currently serving as Strateeg geneesmiddelen at KWF Kankerbestrijding since February 2023. Prior positions include Market Access Manager at Bayer Pharmaceuticals and IQVIA Nederland, along with a role as a Board Member for JongBayer. Aljosja has contributed to the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) by organizing masterclasses and seminars. Additional experience encompasses roles as a Business Analyst at Nederlandse Farmaceutische Zorggroep, Research Associate at Medstone, and Research Scholar at both The University of Manchester and Syreon Research Institute. Academic qualifications include a Master of Science in Farmacie from Utrecht University and a Master of Science in Health Economics, Policy & Law from Erasmus University Rotterdam.